23.6
TGF-β シグナル伝達経路は、細胞の成長、分化、接着、運動性、および発生を調節します。 TGF-β シグナル伝達を誘導する TGF-β リガンドは、潜在型で合成されます。 いくつかのプロテアーゼまたはインテグリンなどの細胞表面受容体が潜在型に作用し、活性リガンドを放出します。 哺乳類の TGF-β…
トランスフォーミング成長因子-βまたはTGF-βシグナル伝達経路は、細胞の増殖と分化を調節します。
それは、ホモ二量体セリン/スレオニンキナーゼ受容体(TGF-β受容体タイプ1および2)から始まります。
二量体タンパク質であるTGF-βは、II型TGF-β受容体に結合し、隣接するI型受容体を動員してリン酸化し、活性な四量体複合体を形成します。
活性化されたTGF-β I型受容体は、受容体活性化SmadまたはR-Smadと呼ばれる転写調節因子を動員し、それをリン酸化します。
リン酸化されたR-Smadは、構造変化を起こし、受容体から解離します。
2つのR-Smadは二量体化して非リン酸化co-Smadと結合し、三量体Smad複合体を形成します。
Smad複合体は核に輸送され、そこで核転写因子に結合し、標的遺伝子の転写を調節します。
核ホスファターゼがR-Smadを脱リン酸化すると、複合体は分解し、Smadはサイトゾルに戻されます。
View the full transcript and gain access to JoVE Core videos
Q1: How does TGF-β ligand binding initiate the signaling pathway?
The dimeric TGF-β ligand binds to type II TGF-β receptors, which then recruit and phosphorylate adjacent type I receptors. This phosphorylation activates the type I receptor's serine/threonine kinase domain, forming an active tetrameric receptor complex that propagates the signal downstream through Smad protein phosphorylation.
Q2: What role do R-Smads play in TGF-β signal transduction?
Receptor-activated Smads (R-Smads) such as Smad2 and Smad3 are phosphorylated by activated type I receptors. This phosphorylation unmasks their nuclear localization signal, allowing two R-Smads to dimerize with an unphosphorylated co-Smad like Smad4, forming a trimeric complex that translocates to the nucleus to regulate gene expression.
Q3: How does the Smad complex regulate gene transcription in the nucleus?
The trimeric Smad complex associates with nuclear transcription factors such as TFE3 and binds to gene regulatory sequences in target genes. This binding induces gene expression and elicits appropriate cellular responses. Once the response is complete, nuclear phosphatases dephosphorylate R-Smads, causing complex disassembly and Smad translocation back to the cytosol.
Q4: What are the three mechanisms by which inhibitory Smads downregulate TGF-β signaling?
Inhibitory Smads (I-Smads) such as Smad6 and Smad7 suppress signaling through three pathways: competing with R-Smads for receptor binding to prevent phosphorylation, recruiting Smurfs to ubiquitylate and degrade receptors, and recruiting phosphatases to dephosphorylate receptors. I-Smads also target co-Smad4 for ubiquitylation and degradation.
Q5: How are latent TGF-β ligands activated before pathway initiation?
TGF-β ligands are synthesized in their latent form and require activation before signaling. Proteases or cell surface receptors such as integrins act upon the latent form to release the active ligand. Three mammalian TGF-β isoforms (TGF-β1, TGF-β2, and TGF-β3) bind as homodimers or heterodimers to activate the signaling pathway.
Q6: What is the function of type III TGF-β receptors in ligand presentation?
Type III receptors (RIII) are cell-surface proteoglycans with glycosaminoglycan chains that bind TGF-β ligands first and present them to type II receptors. Alternatively, ligands may directly bind the constitutively active type II receptor. This dual mechanism ensures efficient recruitment and activation of the receptor complex.
Q7: How does TGF-β signaling compare to other kinase receptor pathways?
TGF-β signaling uses serine/threonine kinase receptors and Smad proteins as signal transducers, distinct from receptor tyrosine kinases that activate alternative cascades. While TGF-β regulates cell proliferation and differentiation through Smad-mediated transcription, other signaling pathways like the JAK-STAT signaling pathway employ different receptor types and effector molecules for cellular responses.